Not applicableStudy completedNCT07378150What this trial is testingClay Therapy in Schizophrenia PatientsWho this might be right forSchizophrenia and Related Disorders Kutahya Health Sciences University 17
Post-approval studies (Phase 4)Study completedNCT00428350What this trial is testingStudy of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute SchizophrenicWho this might be right forSchizophrenia AstraZeneca 120
Post-approval studies (Phase 4)Study completedNCT00779506What this trial is testingStudy of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)Who this might be right forSchizophrenia AstraZeneca 96
Post-approval studies (Phase 4)Study completedNCT01109147What this trial is testingComparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic PatientsWho this might be right forSchizophrenia, Undifferentiated Type Qualissima 67
Large-scale testing (Phase 3)Study completedNCT00150176What this trial is testingTo Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)Who this might be right forSchizophrenia Organon and Co 831
Testing effectiveness (Phase 2)Study completedNCT00653406What this trial is testingA Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic PatientsWho this might be right forSchizophrenia Janssen Pharmaceutical K.K. 29
Testing effectiveness (Phase 2)Study completedNCT01450514What this trial is testingPOC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic SchizophreniaWho this might be right forChronic SchizophreniaSchizoaffective Disorder PharmaNeuroBoost N.V. 7
Not applicableStudy completedNCT00448630What this trial is testingAn Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical AntipsychoticsWho this might be right forSchizophreniaMetabolic Syndrome X Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 328
Not applicableStudy completedNCT01037075What this trial is testingInfluence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug DependenceWho this might be right forSchizophreniaDrug Abuse/Dependency National Institute on Drug Abuse (NIDA) 82
Post-approval studies (Phase 4)Study completedNCT01663077What this trial is testingClozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic PatientsWho this might be right forSchizophrenia Tirat Carmel Mental Health Center 20
Not applicableStudy completedNCT00782899What this trial is testingFour Dimensions in SchizophreniaWho this might be right forSchizophrenia AstraZeneca 320
Not applicableStudy completedNCT06787781What this trial is testingMetabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic SubjectsWho this might be right forMetabolic EvaluationCardiac Complications University of Messina 15
Not applicableStudy completedNCT00572247What this trial is testingThe Psychiatric Rehabilitation Approach to Weight LossWho this might be right forSchizophrenic Disorders University of Kansas 133
Testing effectiveness (Phase 2)Study completedNCT00369577What this trial is testingStaccato Loxapine in Agitation (Proof of Concept)Who this might be right forSchizophrenia Alexza Pharmaceuticals, Inc. 129
Not applicableEnded earlyNCT00506909What this trial is testingOxytocin Add on Study for Stable Schizophrenic PatientsWho this might be right forSchizophrenia David Feifel 21
Not applicableStudy completedNCT04240496What this trial is testingClinical and Genetic Influencing Factors on Clozapine PharmacokineticsWho this might be right forCYP1A2 PolymorphismCYP2C19 PolymorphismClozapine+1 more University of Monastir 51
Post-approval studies (Phase 4)Study completedNCT00304616What this trial is testingSWitching to Abilify Trial (SWAT)Who this might be right forSchizophrenia Korea Otsuka Pharmaceutical Co., Ltd. 500
Post-approval studies (Phase 4)Study completedNCT06041646What this trial is testingTachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar DisorderWho this might be right forBipolar DisorderSchizophreniaAgitation,Psychomotor+2 more BioXcel Therapeutics Inc 29
Large-scale testing (Phase 3)Ended earlyNCT00660595What this trial is testingStudy in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible DoseWho this might be right forSchizophrenic Disorders AstraZeneca 29
Post-approval studies (Phase 4)Study completedNCT00761605What this trial is testingPhase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic ParticipantsWho this might be right forSchizophrenia Janssen Korea, Ltd., Korea 387